FP0391 Confidence, Glucosamine Plus, With Hyaluronic Acid + Curcumin & Boswellia, 60 Extended…
Recalling firm: Confidence Inc./Confidence U.S.A. Inc.
Product contains undeclared ingredients, Hydroxypropyl Methylcellulose (HPMC), Titanium Dioxide, Polyethylene Glycol (PEG), Triacetin.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Oct 22, 2019.
Check your package
Compare the exact product and package details with the label you have.
892483001069FDA code information
Lot# 030616
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
FP0391 Confidence, Glucosamine Plus, With Hyaluronic Acid + Curcumin & Boswellia, 60 Extended Release Tablets, UPC: 8 92483 00106 9
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 892483001069 | With Hyaluronic Acid + Curcumin & Boswellia, 60 Extended Release Tablets, UPC: 8 92483 00106 9 |
| lot | 030616 | Lot# 030616 |
Original FDA recall reason
Product contains undeclared ingredients, Hydroxypropyl Methylcellulose (HPMC), Titanium Dioxide, Polyethylene Glycol (PEG), Triacetin.
Recall details
- Recall number
- F-1816-2018
- Event ID
- 80620
- FDA status
- Terminated
- Initiated
- Jul 26, 2018
- Reported
- Aug 22, 2018
- Classified
- Aug 13, 2018
- Terminated
- Oct 22, 2019
- Quantity
- 5,650 bottles in US distribution (total for all products)
- Location
- Port Washington, NY, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Nationwide
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.